Neuronetics, Inc.
STIM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -2.1% | 19.2% | 42.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 45.9% | 46.6% | 49.2% | 66.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -17.3% | -18.8% | -30.8% | -47.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -24.3% | -26.6% | -39.6% | -56.3% |
| EPS Diluted | -0.13 | -0.15 | -0.21 | -0.33 |
| % Growth | 13.3% | 28.6% | 36.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |